Global Non-invasive Tumor Detection Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08244232

Publication Date:

August 7, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Non-invasive Tumor Detection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淣on-invasive Tumor Detection Industry Forecast鈥� looks at past sales and reviews total world Non-invasive Tumor Detection sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-invasive Tumor Detection sales for 2023 through 2029. With Non-invasive Tumor Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive Tumor Detection industry.
This Insight Report provides a comprehensive analysis of the global Non-invasive Tumor Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-invasive Tumor Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Non-invasive Tumor Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive Tumor Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive Tumor Detection.
United States market for Non-invasive Tumor Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Non-invasive Tumor Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Non-invasive Tumor Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Non-invasive Tumor Detection players cover Datar Cancer Genetics, Nucleix, bioAffinity Technologies, miR Scientific, Nonacus, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Tumor Detection market by product type, application, key players and key regions and countries.
Segmentation by Type:
DNA
RNA
Segmentation by Application:
Prostate Cancer
Bladder Cancer
Pancreatic Cancer
Breast Cancer
Gastric Cancer
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
DNA
RNA
Segmentation by Application:
Prostate Cancer
Bladder Cancer
Pancreatic Cancer
Breast Cancer
Gastric Cancer
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Datar Cancer Genetics
Nucleix
bioAffinity Technologies
miR Scientific
Nonacus
Natera
Penn Medicine

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-invasive Tumor Detection Market Size 2019-2030
2.1.2 Non-invasive Tumor Detection Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Non-invasive Tumor Detection by Country/Region, 2019, 2023 & 2030
2.2 Non-invasive Tumor Detection Segment by Type
2.2.1 DNA
2.2.2 RNA
2.3 Non-invasive Tumor Detection Market Size by Type
2.3.1 Non-invasive Tumor Detection Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Non-invasive Tumor Detection Market Size Market Share by Type (2019-2024)
2.4 Non-invasive Tumor Detection Segment by Application
2.4.1 Prostate Cancer
2.4.2 Bladder Cancer
2.4.3 Pancreatic Cancer
2.4.4 Breast Cancer
2.4.5 Gastric Cancer
2.4.6 Others
2.5 Non-invasive Tumor Detection Market Size by Application
2.5.1 Non-invasive Tumor Detection Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Non-invasive Tumor Detection Market Size Market Share by Application (2019-2024)
3 Non-invasive Tumor Detection Market Size by Player
3.1 Non-invasive Tumor Detection Market Size Market Share by Player
3.1.1 Global Non-invasive Tumor Detection Revenue by Player (2019-2024)
3.1.2 Global Non-invasive Tumor Detection Revenue Market Share by Player (2019-2024)
3.2 Global Non-invasive Tumor Detection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Non-invasive Tumor Detection by Region
4.1 Non-invasive Tumor Detection Market Size by Region (2019-2024)
4.2 Global Non-invasive Tumor Detection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Non-invasive Tumor Detection Market Size Growth (2019-2024)
4.4 APAC Non-invasive Tumor Detection Market Size Growth (2019-2024)
4.5 Europe Non-invasive Tumor Detection Market Size Growth (2019-2024)
4.6 Middle East & Africa Non-invasive Tumor Detection Market Size Growth (2019-2024)
5 Americas
5.1 Americas Non-invasive Tumor Detection Market Size by Country (2019-2024)
5.2 Americas Non-invasive Tumor Detection Market Size by Type (2019-2024)
5.3 Americas Non-invasive Tumor Detection Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive Tumor Detection Market Size by Region (2019-2024)
6.2 APAC Non-invasive Tumor Detection Market Size by Type (2019-2024)
6.3 APAC Non-invasive Tumor Detection Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Non-invasive Tumor Detection Market Size by Country (2019-2024)
7.2 Europe Non-invasive Tumor Detection Market Size by Type (2019-2024)
7.3 Europe Non-invasive Tumor Detection Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-invasive Tumor Detection by Region (2019-2024)
8.2 Middle East & Africa Non-invasive Tumor Detection Market Size by Type (2019-2024)
8.3 Middle East & Africa Non-invasive Tumor Detection Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Non-invasive Tumor Detection Market Forecast
10.1 Global Non-invasive Tumor Detection Forecast by Region (2025-2030)
10.1.1 Global Non-invasive Tumor Detection Forecast by Region (2025-2030)
10.1.2 Americas Non-invasive Tumor Detection Forecast
10.1.3 APAC Non-invasive Tumor Detection Forecast
10.1.4 Europe Non-invasive Tumor Detection Forecast
10.1.5 Middle East & Africa Non-invasive Tumor Detection Forecast
10.2 Americas Non-invasive Tumor Detection Forecast by Country (2025-2030)
10.2.1 United States Market Non-invasive Tumor Detection Forecast
10.2.2 Canada Market Non-invasive Tumor Detection Forecast
10.2.3 Mexico Market Non-invasive Tumor Detection Forecast
10.2.4 Brazil Market Non-invasive Tumor Detection Forecast
10.3 APAC Non-invasive Tumor Detection Forecast by Region (2025-2030)
10.3.1 China Non-invasive Tumor Detection Market Forecast
10.3.2 Japan Market Non-invasive Tumor Detection Forecast
10.3.3 Korea Market Non-invasive Tumor Detection Forecast
10.3.4 Southeast Asia Market Non-invasive Tumor Detection Forecast
10.3.5 India Market Non-invasive Tumor Detection Forecast
10.3.6 Australia Market Non-invasive Tumor Detection Forecast
10.4 Europe Non-invasive Tumor Detection Forecast by Country (2025-2030)
10.4.1 Germany Market Non-invasive Tumor Detection Forecast
10.4.2 France Market Non-invasive Tumor Detection Forecast
10.4.3 UK Market Non-invasive Tumor Detection Forecast
10.4.4 Italy Market Non-invasive Tumor Detection Forecast
10.4.5 Russia Market Non-invasive Tumor Detection Forecast
10.5 Middle East & Africa Non-invasive Tumor Detection Forecast by Region (2025-2030)
10.5.1 Egypt Market Non-invasive Tumor Detection Forecast
10.5.2 South Africa Market Non-invasive Tumor Detection Forecast
10.5.3 Israel Market Non-invasive Tumor Detection Forecast
10.5.4 Turkey Market Non-invasive Tumor Detection Forecast
10.6 Global Non-invasive Tumor Detection Forecast by Type (2025-2030)
10.7 Global Non-invasive Tumor Detection Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Non-invasive Tumor Detection Forecast
11 Key Players Analysis
11.1 Datar Cancer Genetics
11.1.1 Datar Cancer Genetics Company Information
11.1.2 Datar Cancer Genetics Non-invasive Tumor Detection Product Offered
11.1.3 Datar Cancer Genetics Non-invasive Tumor Detection Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Datar Cancer Genetics Main Business Overview
11.1.5 Datar Cancer Genetics Latest Developments
11.2 Nucleix
11.2.1 Nucleix Company Information
11.2.2 Nucleix Non-invasive Tumor Detection Product Offered
11.2.3 Nucleix Non-invasive Tumor Detection Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Nucleix Main Business Overview
11.2.5 Nucleix Latest Developments
11.3 bioAffinity Technologies
11.3.1 bioAffinity Technologies Company Information
11.3.2 bioAffinity Technologies Non-invasive Tumor Detection Product Offered
11.3.3 bioAffinity Technologies Non-invasive Tumor Detection Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 bioAffinity Technologies Main Business Overview
11.3.5 bioAffinity Technologies Latest Developments
11.4 miR Scientific
11.4.1 miR Scientific Company Information
11.4.2 miR Scientific Non-invasive Tumor Detection Product Offered
11.4.3 miR Scientific Non-invasive Tumor Detection Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 miR Scientific Main Business Overview
11.4.5 miR Scientific Latest Developments
11.5 Nonacus
11.5.1 Nonacus Company Information
11.5.2 Nonacus Non-invasive Tumor Detection Product Offered
11.5.3 Nonacus Non-invasive Tumor Detection Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Nonacus Main Business Overview
11.5.5 Nonacus Latest Developments
11.6 Natera
11.6.1 Natera Company Information
11.6.2 Natera Non-invasive Tumor Detection Product Offered
11.6.3 Natera Non-invasive Tumor Detection Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Natera Main Business Overview
11.6.5 Natera Latest Developments
11.7 Penn Medicine
11.7.1 Penn Medicine Company Information
11.7.2 Penn Medicine Non-invasive Tumor Detection Product Offered
11.7.3 Penn Medicine Non-invasive Tumor Detection Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Penn Medicine Main Business Overview
11.7.5 Penn Medicine Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂